English
简体中文
Total: £ 56.28
Published Date: 2026-04-08 | Pages: 143 | Tables: 143 | Medical Care
The global Phage Therapy market was valued at US$ 65.57 million in 2025 and is anticipated to reach US$ 221 million by 2032, at a CAGR of 19.3% from 2026 to 2032.
Phages, formally known as bacteriophages, are viruses that solely kill and selectively target bacteria. They are the most common biological entities in nature, and have been shown to effectively fight and destroy multi-drug resistant bacteria. Namely, when all antibiotics fail, phages still succeed in killing the bacteria and may save a life from an infection. phage has many potential applications in human medicine as well as dentistry, veterinary science, and agriculture.
The Bacteriophage market is expected to grow at a significant rate owing to rising prevalence of antibiotic resistant infection, rising research activities for and development of novel therapies, increasing adoption of growth strategies such as acquisitions, and collaborations by market players.
Bacteriophage is a type of virus that attaches itself to a bacterium and infects the host cell, subsequently destroying it. These microorganisms destroy their host cells through a natural process without interacting with human or animal cells. One of the most important sectors where the use of bacteriophages has emerged as very important is the poultry and aquaculture. While the use of bacteriophages in humans is still a rarity in modern medicine, their usage in animal husbandry, rearing poultry and fish is already showing positive results.
The major global companies of Bacteriophage include NPO Microgen, Qingdao Phagepharm Bio-tech, Armata Pharmaceuticals, Inc., Phaxiam Therapeutics, Eliava BioPreparations, Intralytix, MicroMir, Phagelux, and Pharmex Group, LLC, etc. In 2024, the world's top five vendors accounted for approximately 48% of the revenue.
This report delivers a comprehensive overview of the global Phage Therapy market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Phage Therapy. The Phage Therapy market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Phage Therapy market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Phage Therapy manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
NPO Microgen
Qingdao Phagepharm Bio-tech
Armata Pharmaceuticals, Inc.
Phaxiam Therapeutics
Eliava BioPreparations
Intralytix
MicroMir
Phagelux
Pharmex Group, LLC
APS Biocontrol Ltd. (APS)
ACD Pharma
Proteon Pharmaceuticals
Micreos
Locus Biosciences, Inc
NexaBiome Limited
PhagePro
BiomX
INtODEWORLD, Inc.
TechnoPhage
PhageLab
SciPhage
Kinzbio
Segment by Type
DsDNA Bacteriophage
SsDNA Bacteriophage
SsRNA Bacteriophage
Others
Segment by Application
Human Health
Animal Health
Aquaculture
Agriculture
Food Industry
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Phage Therapy companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Phage Therapy Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 DsDNA Bacteriophage
1.2.3 SsDNA Bacteriophage
1.2.4 SsRNA Bacteriophage
1.2.5 Others
1.3 Market by Application
1.3.1 Global Phage Therapy Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Human Health
1.3.3 Animal Health
1.3.4 Aquaculture
1.3.5 Agriculture
1.3.6 Food Industry
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Phage Therapy Market Perspective (2021–2032)
2.2 Global Phage Therapy Growth Trends by Region
2.2.1 Global Phage Therapy Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Phage Therapy Historic Market Size by Region (2021–2026)
2.2.3 Phage Therapy Forecasted Market Size by Region (2027–2032)
2.3 Phage Therapy Market Dynamics
2.3.1 Phage Therapy Industry Trends
2.3.2 Phage Therapy Market Drivers
2.3.3 Phage Therapy Market Challenges
2.3.4 Phage Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Phage Therapy Players by Revenue
3.1.1 Global Top Phage Therapy Players by Revenue (2021–2026)
3.1.2 Global Phage Therapy Revenue Market Share by Players (2021–2026)
3.2 Global Top Phage Therapy Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Phage Therapy Revenue
3.4 Global Phage Therapy Market Concentration Ratio
3.4.1 Global Phage Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Phage Therapy Revenue in 2025
3.5 Global Key Players of Phage Therapy Head Offices and Areas Served
3.6 Global Key Players of Phage Therapy, Products and Applications
3.7 Global Key Players of Phage Therapy, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Phage Therapy Breakdown Data by Type
4.1 Global Phage Therapy Historic Market Size by Type (2021–2026)
4.2 Global Phage Therapy Forecasted Market Size by Type (2027–2032)
5 Phage Therapy Breakdown Data by Application
5.1 Global Phage Therapy Historic Market Size by Application (2021–2026)
5.2 Global Phage Therapy Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Phage Therapy Market Size (2021–2032)
6.2 North America Phage Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Phage Therapy Market Size by Country (2021–2026)
6.4 North America Phage Therapy Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Phage Therapy Market Size (2021–2032)
7.2 Europe Phage Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Phage Therapy Market Size by Country (2021–2026)
7.4 Europe Phage Therapy Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Phage Therapy Market Size (2021–2032)
8.2 Asia-Pacific Phage Therapy Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Phage Therapy Market Size by Region (2021–2026)
8.4 Asia-Pacific Phage Therapy Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Phage Therapy Market Size (2021–2032)
9.2 Latin America Phage Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Phage Therapy Market Size by Country (2021–2026)
9.4 Latin America Phage Therapy Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Phage Therapy Market Size (2021–2032)
10.2 Middle East & Africa Phage Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Phage Therapy Market Size by Country (2021–2026)
10.4 Middle East & Africa Phage Therapy Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 NPO Microgen
11.1.1 NPO Microgen Company Details
11.1.2 NPO Microgen Business Overview
11.1.3 NPO Microgen Phage Therapy Introduction
11.1.4 NPO Microgen Revenue in Phage Therapy Business (2021–2026)
11.1.5 NPO Microgen Recent Development
11.2 Qingdao Phagepharm Bio-tech
11.2.1 Qingdao Phagepharm Bio-tech Company Details
11.2.2 Qingdao Phagepharm Bio-tech Business Overview
11.2.3 Qingdao Phagepharm Bio-tech Phage Therapy Introduction
11.2.4 Qingdao Phagepharm Bio-tech Revenue in Phage Therapy Business (2021–2026)
11.2.5 Qingdao Phagepharm Bio-tech Recent Development
11.3 Armata Pharmaceuticals, Inc.
11.3.1 Armata Pharmaceuticals, Inc. Company Details
11.3.2 Armata Pharmaceuticals, Inc. Business Overview
11.3.3 Armata Pharmaceuticals, Inc. Phage Therapy Introduction
11.3.4 Armata Pharmaceuticals, Inc. Revenue in Phage Therapy Business (2021–2026)
11.3.5 Armata Pharmaceuticals, Inc. Recent Development
11.4 Phaxiam Therapeutics
11.4.1 Phaxiam Therapeutics Company Details
11.4.2 Phaxiam Therapeutics Business Overview
11.4.3 Phaxiam Therapeutics Phage Therapy Introduction
11.4.4 Phaxiam Therapeutics Revenue in Phage Therapy Business (2021–2026)
11.4.5 Phaxiam Therapeutics Recent Development
11.5 Eliava BioPreparations
11.5.1 Eliava BioPreparations Company Details
11.5.2 Eliava BioPreparations Business Overview
11.5.3 Eliava BioPreparations Phage Therapy Introduction
11.5.4 Eliava BioPreparations Revenue in Phage Therapy Business (2021–2026)
11.5.5 Eliava BioPreparations Recent Development
11.6 Intralytix
11.6.1 Intralytix Company Details
11.6.2 Intralytix Business Overview
11.6.3 Intralytix Phage Therapy Introduction
11.6.4 Intralytix Revenue in Phage Therapy Business (2021–2026)
11.6.5 Intralytix Recent Development
11.7 MicroMir
11.7.1 MicroMir Company Details
11.7.2 MicroMir Business Overview
11.7.3 MicroMir Phage Therapy Introduction
11.7.4 MicroMir Revenue in Phage Therapy Business (2021–2026)
11.7.5 MicroMir Recent Development
11.8 Phagelux
11.8.1 Phagelux Company Details
11.8.2 Phagelux Business Overview
11.8.3 Phagelux Phage Therapy Introduction
11.8.4 Phagelux Revenue in Phage Therapy Business (2021–2026)
11.8.5 Phagelux Recent Development
11.9 Pharmex Group, LLC
11.9.1 Pharmex Group, LLC Company Details
11.9.2 Pharmex Group, LLC Business Overview
11.9.3 Pharmex Group, LLC Phage Therapy Introduction
11.9.4 Pharmex Group, LLC Revenue in Phage Therapy Business (2021–2026)
11.9.5 Pharmex Group, LLC Recent Development
11.10 APS Biocontrol Ltd. (APS)
11.10.1 APS Biocontrol Ltd. (APS) Company Details
11.10.2 APS Biocontrol Ltd. (APS) Business Overview
11.10.3 APS Biocontrol Ltd. (APS) Phage Therapy Introduction
11.10.4 APS Biocontrol Ltd. (APS) Revenue in Phage Therapy Business (2021–2026)
11.10.5 APS Biocontrol Ltd. (APS) Recent Development
11.11 ACD Pharma
11.11.1 ACD Pharma Company Details
11.11.2 ACD Pharma Business Overview
11.11.3 ACD Pharma Phage Therapy Introduction
11.11.4 ACD Pharma Revenue in Phage Therapy Business (2021–2026)
11.11.5 ACD Pharma Recent Development
11.12 Proteon Pharmaceuticals
11.12.1 Proteon Pharmaceuticals Company Details
11.12.2 Proteon Pharmaceuticals Business Overview
11.12.3 Proteon Pharmaceuticals Phage Therapy Introduction
11.12.4 Proteon Pharmaceuticals Revenue in Phage Therapy Business (2021–2026)
11.12.5 Proteon Pharmaceuticals Recent Development
11.13 Micreos
11.13.1 Micreos Company Details
11.13.2 Micreos Business Overview
11.13.3 Micreos Phage Therapy Introduction
11.13.4 Micreos Revenue in Phage Therapy Business (2021–2026)
11.13.5 Micreos Recent Development
11.14 Locus Biosciences, Inc
11.14.1 Locus Biosciences, Inc Company Details
11.14.2 Locus Biosciences, Inc Business Overview
11.14.3 Locus Biosciences, Inc Phage Therapy Introduction
11.14.4 Locus Biosciences, Inc Revenue in Phage Therapy Business (2021–2026)
11.14.5 Locus Biosciences, Inc Recent Development
11.15 NexaBiome Limited
11.15.1 NexaBiome Limited Company Details
11.15.2 NexaBiome Limited Business Overview
11.15.3 NexaBiome Limited Phage Therapy Introduction
11.15.4 NexaBiome Limited Revenue in Phage Therapy Business (2021–2026)
11.15.5 NexaBiome Limited Recent Development
11.16 PhagePro
11.16.1 PhagePro Company Details
11.16.2 PhagePro Business Overview
11.16.3 PhagePro Phage Therapy Introduction
11.16.4 PhagePro Revenue in Phage Therapy Business (2021–2026)
11.16.5 PhagePro Recent Development
11.17 BiomX
11.17.1 BiomX Company Details
11.17.2 BiomX Business Overview
11.17.3 BiomX Phage Therapy Introduction
11.17.4 BiomX Revenue in Phage Therapy Business (2021–2026)
11.17.5 BiomX Recent Development
11.18 INtODEWORLD, Inc.
11.18.1 INtODEWORLD, Inc. Company Details
11.18.2 INtODEWORLD, Inc. Business Overview
11.18.3 INtODEWORLD, Inc. Phage Therapy Introduction
11.18.4 INtODEWORLD, Inc. Revenue in Phage Therapy Business (2021–2026)
11.18.5 INtODEWORLD, Inc. Recent Development
11.19 TechnoPhage
11.19.1 TechnoPhage Company Details
11.19.2 TechnoPhage Business Overview
11.19.3 TechnoPhage Phage Therapy Introduction
11.19.4 TechnoPhage Revenue in Phage Therapy Business (2021–2026)
11.19.5 TechnoPhage Recent Development
11.20 PhageLab
11.20.1 PhageLab Company Details
11.20.2 PhageLab Business Overview
11.20.3 PhageLab Phage Therapy Introduction
11.20.4 PhageLab Revenue in Phage Therapy Business (2021–2026)
11.20.5 PhageLab Recent Development
11.21 SciPhage
11.21.1 SciPhage Company Details
11.21.2 SciPhage Business Overview
11.21.3 SciPhage Phage Therapy Introduction
11.21.4 SciPhage Revenue in Phage Therapy Business (2021–2026)
11.21.5 SciPhage Recent Development
11.22 Kinzbio
11.22.1 Kinzbio Company Details
11.22.2 Kinzbio Business Overview
11.22.3 Kinzbio Phage Therapy Introduction
11.22.4 Kinzbio Revenue in Phage Therapy Business (2021–2026)
11.22.5 Kinzbio Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Phage Therapy Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of DsDNA Bacteriophage
Table 3. Key Players of SsDNA Bacteriophage
Table 4. Key Players of SsRNA Bacteriophage
Table 5. Key Players of Others
Table 6. Global Phage Therapy Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 7. Global Phage Therapy Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 8. Global Phage Therapy Market Size by Region (US$ Million), 2021–2026
Table 9. Global Phage Therapy Market Share by Region (2021–2026)
Table 10. Global Phage Therapy Forecasted Market Size by Region (US$ Million), 2027–2032
Table 11. Global Phage Therapy Market Share by Region (2027–2032)
Table 12. Phage Therapy Market Trends
Table 13. Phage Therapy Market Drivers
Table 14. Phage Therapy Market Challenges
Table 15. Phage Therapy Market Restraints
Table 16. Global Phage Therapy Revenue by Players (US$ Million), 2021–2026
Table 17. Global Phage Therapy Market Share by Players (2021–2026)
Table 18. Global Top Phage Therapy Players by Tier (Tier 1, Tier 2, and Tier 3), based on Phage Therapy Revenue, 2025
Table 19. Ranking of Global Top Phage Therapy Companies by Revenue (US$ Million) in 2025
Table 20. Global 5 Largest Players Market Share by Phage Therapy Revenue (CR5 and HHI), 2021–2026
Table 21. Global Key Players of Phage Therapy, Headquarters and Area Served
Table 22. Global Key Players of Phage Therapy, Products and Applications
Table 23. Global Key Players of Phage Therapy, Date of General Availability (GA)
Table 24. Mergers and Acquisitions, Expansion Plans
Table 25. Global Phage Therapy Market Size by Type (US$ Million), 2021–2026
Table 26. Global Phage Therapy Revenue Market Share by Type (2021–2026)
Table 27. Global Phage Therapy Forecasted Market Size by Type (US$ Million), 2027–2032
Table 28. Global Phage Therapy Revenue Market Share by Type (2027–2032)
Table 29. Global Phage Therapy Market Size by Application (US$ Million), 2021–2026
Table 30. Global Phage Therapy Revenue Market Share by Application (2021–2026)
Table 31. Global Phage Therapy Forecasted Market Size by Application (US$ Million), 2027–2032
Table 32. Global Phage Therapy Revenue Market Share by Application (2027–2032)
Table 33. North America Phage Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 34. North America Phage Therapy Market Size by Country (US$ Million), 2021–2026
Table 35. North America Phage Therapy Market Size by Country (US$ Million), 2027–2032
Table 36. Europe Phage Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 37. Europe Phage Therapy Market Size by Country (US$ Million), 2021–2026
Table 38. Europe Phage Therapy Market Size by Country (US$ Million), 2027–2032
Table 39. Asia-Pacific Phage Therapy Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 40. Asia-Pacific Phage Therapy Market Size by Region (US$ Million), 2021–2026
Table 41. Asia-Pacific Phage Therapy Market Size by Region (US$ Million), 2027–2032
Table 42. Latin America Phage Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 43. Latin America Phage Therapy Market Size by Country (US$ Million), 2021–2026
Table 44. Latin America Phage Therapy Market Size by Country (US$ Million), 2027–2032
Table 45. Middle East & Africa Phage Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 46. Middle East & Africa Phage Therapy Market Size by Country (US$ Million), 2021–2026
Table 47. Middle East & Africa Phage Therapy Market Size by Country (US$ Million), 2027–2032
Table 48. NPO Microgen Company Details
Table 49. NPO Microgen Business Overview
Table 50. NPO Microgen Phage Therapy Product
Table 51. NPO Microgen Revenue in Phage Therapy Business (US$ Million), 2021–2026
Table 52. NPO Microgen Recent Development
Table 53. Qingdao Phagepharm Bio-tech Company Details
Table 54. Qingdao Phagepharm Bio-tech Business Overview
Table 55. Qingdao Phagepharm Bio-tech Phage Therapy Product
Table 56. Qingdao Phagepharm Bio-tech Revenue in Phage Therapy Business (US$ Million), 2021–2026
Table 57. Qingdao Phagepharm Bio-tech Recent Development
Table 58. Armata Pharmaceuticals, Inc. Company Details
Table 59. Armata Pharmaceuticals, Inc. Business Overview
Table 60. Armata Pharmaceuticals, Inc. Phage Therapy Product
Table 61. Armata Pharmaceuticals, Inc. Revenue in Phage Therapy Business (US$ Million), 2021–2026
Table 62. Armata Pharmaceuticals, Inc. Recent Development
Table 63. Phaxiam Therapeutics Company Details
Table 64. Phaxiam Therapeutics Business Overview
Table 65. Phaxiam Therapeutics Phage Therapy Product
Table 66. Phaxiam Therapeutics Revenue in Phage Therapy Business (US$ Million), 2021–2026
Table 67. Phaxiam Therapeutics Recent Development
Table 68. Eliava BioPreparations Company Details
Table 69. Eliava BioPreparations Business Overview
Table 70. Eliava BioPreparations Phage Therapy Product
Table 71. Eliava BioPreparations Revenue in Phage Therapy Business (US$ Million), 2021–2026
Table 72. Eliava BioPreparations Recent Development
Table 73. Intralytix Company Details
Table 74. Intralytix Business Overview
Table 75. Intralytix Phage Therapy Product
Table 76. Intralytix Revenue in Phage Therapy Business (US$ Million), 2021–2026
Table 77. Intralytix Recent Development
Table 78. MicroMir Company Details
Table 79. MicroMir Business Overview
Table 80. MicroMir Phage Therapy Product
Table 81. MicroMir Revenue in Phage Therapy Business (US$ Million), 2021–2026
Table 82. MicroMir Recent Development
Table 83. Phagelux Company Details
Table 84. Phagelux Business Overview
Table 85. Phagelux Phage Therapy Product
Table 86. Phagelux Revenue in Phage Therapy Business (US$ Million), 2021–2026
Table 87. Phagelux Recent Development
Table 88. Pharmex Group, LLC Company Details
Table 89. Pharmex Group, LLC Business Overview
Table 90. Pharmex Group, LLC Phage Therapy Product
Table 91. Pharmex Group, LLC Revenue in Phage Therapy Business (US$ Million), 2021–2026
Table 92. Pharmex Group, LLC Recent Development
Table 93. APS Biocontrol Ltd. (APS) Company Details
Table 94. APS Biocontrol Ltd. (APS) Business Overview
Table 95. APS Biocontrol Ltd. (APS) Phage Therapy Product
Table 96. APS Biocontrol Ltd. (APS) Revenue in Phage Therapy Business (US$ Million), 2021–2026
Table 97. APS Biocontrol Ltd. (APS) Recent Development
Table 98. ACD Pharma Company Details
Table 99. ACD Pharma Business Overview
Table 100. ACD Pharma Phage Therapy Product
Table 101. ACD Pharma Revenue in Phage Therapy Business (US$ Million), 2021–2026
Table 102. ACD Pharma Recent Development
Table 103. Proteon Pharmaceuticals Company Details
Table 104. Proteon Pharmaceuticals Business Overview
Table 105. Proteon Pharmaceuticals Phage Therapy Product
Table 106. Proteon Pharmaceuticals Revenue in Phage Therapy Business (US$ Million), 2021–2026
Table 107. Proteon Pharmaceuticals Recent Development
Table 108. Micreos Company Details
Table 109. Micreos Business Overview
Table 110. Micreos Phage Therapy Product
Table 111. Micreos Revenue in Phage Therapy Business (US$ Million), 2021–2026
Table 112. Micreos Recent Development
Table 113. Locus Biosciences, Inc Company Details
Table 114. Locus Biosciences, Inc Business Overview
Table 115. Locus Biosciences, Inc Phage Therapy Product
Table 116. Locus Biosciences, Inc Revenue in Phage Therapy Business (US$ Million), 2021–2026
Table 117. Locus Biosciences, Inc Recent Development
Table 118. NexaBiome Limited Company Details
Table 119. NexaBiome Limited Business Overview
Table 120. NexaBiome Limited Phage Therapy Product
Table 121. NexaBiome Limited Revenue in Phage Therapy Business (US$ Million), 2021–2026
Table 122. NexaBiome Limited Recent Development
Table 123. PhagePro Company Details
Table 124. PhagePro Business Overview
Table 125. PhagePro Phage Therapy Product
Table 126. PhagePro Revenue in Phage Therapy Business (US$ Million), 2021–2026
Table 127. PhagePro Recent Development
Table 128. BiomX Company Details
Table 129. BiomX Business Overview
Table 130. BiomX Phage Therapy Product
Table 131. BiomX Revenue in Phage Therapy Business (US$ Million), 2021–2026
Table 132. BiomX Recent Development
Table 133. INtODEWORLD, Inc. Company Details
Table 134. INtODEWORLD, Inc. Business Overview
Table 135. INtODEWORLD, Inc. Phage Therapy Product
Table 136. INtODEWORLD, Inc. Revenue in Phage Therapy Business (US$ Million), 2021–2026
Table 137. INtODEWORLD, Inc. Recent Development
Table 138. TechnoPhage Company Details
Table 139. TechnoPhage Business Overview
Table 140. TechnoPhage Phage Therapy Product
Table 141. TechnoPhage Revenue in Phage Therapy Business (US$ Million), 2021–2026
Table 142. TechnoPhage Recent Development
Table 143. PhageLab Company Details
Table 144. PhageLab Business Overview
Table 145. PhageLab Phage Therapy Product
Table 146. PhageLab Revenue in Phage Therapy Business (US$ Million), 2021–2026
Table 147. PhageLab Recent Development
Table 148. SciPhage Company Details
Table 149. SciPhage Business Overview
Table 150. SciPhage Phage Therapy Product
Table 151. SciPhage Revenue in Phage Therapy Business (US$ Million), 2021–2026
Table 152. SciPhage Recent Development
Table 153. Kinzbio Company Details
Table 154. Kinzbio Business Overview
Table 155. Kinzbio Phage Therapy Product
Table 156. Kinzbio Revenue in Phage Therapy Business (US$ Million), 2021–2026
Table 157. Kinzbio Recent Development
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
Table 161. Authors List of This Report
List of Figures
Figure 1. Phage Therapy Picture
Figure 2. Global Phage Therapy Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Phage Therapy Market Share by Type: 2025 vs 2032
Figure 4. DsDNA Bacteriophage Features
Figure 5. SsDNA Bacteriophage Features
Figure 6. SsRNA Bacteriophage Features
Figure 7. Others Features
Figure 8. Global Phage Therapy Market Size by Application (US$ Million), 2021–2032
Figure 9. Global Phage Therapy Market Share by Application: 2025 vs 2032
Figure 10. Human Health Case Studies
Figure 11. Animal Health Case Studies
Figure 12. Aquaculture Case Studies
Figure 13. Agriculture Case Studies
Figure 14. Food Industry Case Studies
Figure 15. Others Case Studies
Figure 16. Phage Therapy Report Years Considered
Figure 17. Global Phage Therapy Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 18. Global Phage Therapy Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 19. Global Phage Therapy Market Share by Region: 2025 vs 2032
Figure 20. Global Phage Therapy Market Share by Players in 2025
Figure 21. Global Phage Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 22. The Top 10 and 5 Players Market Share by Phage Therapy Revenue in 2025
Figure 23. North America Phage Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. North America Phage Therapy Market Share by Country (2021–2032)
Figure 25. United States Phage Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. Canada Phage Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. Europe Phage Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Europe Phage Therapy Market Share by Country (2021–2032)
Figure 29. Germany Phage Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. France Phage Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. U.K. Phage Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Italy Phage Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Russia Phage Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Ireland Phage Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Asia-Pacific Phage Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Asia-Pacific Phage Therapy Market Share by Region (2021–2032)
Figure 37. China Phage Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Japan Phage Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. South Korea Phage Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Southeast Asia Phage Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. India Phage Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Australia & New Zealand Phage Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Latin America Phage Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Latin America Phage Therapy Market Share by Country (2021–2032)
Figure 45. Mexico Phage Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Brazil Phage Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Middle East & Africa Phage Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. Middle East & Africa Phage Therapy Market Share by Country (2021–2032)
Figure 49. Israel Phage Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 50. Saudi Arabia Phage Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 51. UAE Phage Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 52. NPO Microgen Revenue Growth Rate in Phage Therapy Business (2021–2026)
Figure 53. Qingdao Phagepharm Bio-tech Revenue Growth Rate in Phage Therapy Business (2021–2026)
Figure 54. Armata Pharmaceuticals, Inc. Revenue Growth Rate in Phage Therapy Business (2021–2026)
Figure 55. Phaxiam Therapeutics Revenue Growth Rate in Phage Therapy Business (2021–2026)
Figure 56. Eliava BioPreparations Revenue Growth Rate in Phage Therapy Business (2021–2026)
Figure 57. Intralytix Revenue Growth Rate in Phage Therapy Business (2021–2026)
Figure 58. MicroMir Revenue Growth Rate in Phage Therapy Business (2021–2026)
Figure 59. Phagelux Revenue Growth Rate in Phage Therapy Business (2021–2026)
Figure 60. Pharmex Group, LLC Revenue Growth Rate in Phage Therapy Business (2021–2026)
Figure 61. APS Biocontrol Ltd. (APS) Revenue Growth Rate in Phage Therapy Business (2021–2026)
Figure 62. ACD Pharma Revenue Growth Rate in Phage Therapy Business (2021–2026)
Figure 63. Proteon Pharmaceuticals Revenue Growth Rate in Phage Therapy Business (2021–2026)
Figure 64. Micreos Revenue Growth Rate in Phage Therapy Business (2021–2026)
Figure 65. Locus Biosciences, Inc Revenue Growth Rate in Phage Therapy Business (2021–2026)
Figure 66. NexaBiome Limited Revenue Growth Rate in Phage Therapy Business (2021–2026)
Figure 67. PhagePro Revenue Growth Rate in Phage Therapy Business (2021–2026)
Figure 68. BiomX Revenue Growth Rate in Phage Therapy Business (2021–2026)
Figure 69. INtODEWORLD, Inc. Revenue Growth Rate in Phage Therapy Business (2021–2026)
Figure 70. TechnoPhage Revenue Growth Rate in Phage Therapy Business (2021–2026)
Figure 71. PhageLab Revenue Growth Rate in Phage Therapy Business (2021–2026)
Figure 72. SciPhage Revenue Growth Rate in Phage Therapy Business (2021–2026)
Figure 73. Kinzbio Revenue Growth Rate in Phage Therapy Business (2021–2026)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed
